| | Your search for Galen E Switzer returned the following results: |
Physician awareness and self-reported use of local and national guidelines for community-acquired pneumoniaJ Gen Intern Med; 10/01/2003; 18: 10 (816 - 823)
Switzer GE, Halm EA, Chang CC, Mittman BS, Walsh MB, Fine MJ CHERP Investigator(s):
Michael J Fine MD, MSc • Galen E Switzer PhD • Mary B Walsh RN •
Onset, timing and risk for depression and anxiety in family caregivers to heart transplant recipientsPsychol Med; 08/01/2004; 34: 6 (1065 - 1082)
Dew MA, Myaskovsky L, DiMartini AF, Switzer GE, Schulberg HC, Kormos RL. CHERP Investigator(s):
Galen E Switzer PhD •
Attrition of potential bone marrow donors at two key decision points leading to donationTransplantation; 05/01/2004; 77: 10 (1529 - 1534)
Switzer GE, Dew MA, Goycoolea JM, Myaskovsky L, Abress L, Confer DL. CHERP Investigator(s):
Galen E Switzer PhD •
The association of donor center characteristics with attrition from the national marrow donor registryTransplantation; 03/27/2004; 77: 6 (874 - 880)
Myaskovsky L, Switzer GE, Dew MA, Goycoolea JM, Confer DL, Abress L. CHERP Investigator(s):
Galen E Switzer PhD •
HIV-infected African Americans are willing to participate in HIV treatment trialsJ Gen Intern Med; 01/01/2007; 22: 1 (17 - 42)
Garber M, Hanusa BH, Switzer GE, Mellors J, Arnold RM CHERP Investigator(s):
Galen E Switzer PhD • Summary:
Despite the high prevalence rates of HIV infection in the African-American community, African Americans remain underrepresented in HIV treatment trials. In a sample of 200 HIV-infected African-American adults receiving medical care at the Pittsburgh AIDS Center for Treatment (a university-based ambulatory clinic), we assessed research participation rates and willingness to participate in future HIV treatment trials, trust in the medical profession, sociodemographic characteristics, attitudes, and concerns about HIV treatment trials. Only 57% of survey respondents had ever been asked to participate in an HIV treatment trial but 86% of those asked said yes. Prior research participation was significantly related to willingness to participate in future HIV treatment trials (P = .001). Contrary to previous studies, neither trust/distrust in the medical profession nor beliefs about the dishonesty of researchers was associated with research participation rates or willingness to participate in future HIV treatment trials. Having never been asked to participate in research is a major barrier to the participation of HIV-infected African Americans in HIV treatment trials. African Americans who seek medical care for HIV infection should be asked to participate in HIV treatment trials.
Nondirected living donation: a survey of current trends and practicesTransplantation; 03/15/2005; 79: 5 (515 - 519)
Crowley-Matoka M, Switzer G CHERP Investigator(s):
Megan Crowley Matoka PhD • Galen E Switzer PhD •
Quality of life and coping strategies among lung transplant candidates and their family caregiversSoc Sci Med; 05/01/2005; 60: 10 (2321 - 2332)
Myaskovsky L, Dew MA, Switzer GE, McNulty ML, DiMartini AF, McCurry KR. CHERP Investigator(s):
Larissa Myaskovsky PhD • Galen E Switzer PhD • Summary:
Adult lung transplant candidates and their caregivers (N=114 pairs) participated in semi-structured interviews that included measures of QOL and coping with patients' health-related problems. Better patient QOL, across multiple domains, was associated with better caregiver QOL. Multiple elements of patients' coping, including greater use of active coping and emotionally oriented coping were related to generally poorer patient QOL in psychosocial and physical domains. Similarly, caregivers who used more emotionally oriented coping had poorer QOL. There was no statistically reliable relationship between either(a)patient and caregiver use of coping strategies, or (b) caregiver coping and patient QOL. However, patients' coping strategies were important correlates of caregivers' QOL. These findings belie common clinical beliefs that family members' coping responses to patients' health are likely to affect patient well-being. Instead, patients' coping and QOL may be critical for understanding caregiver well-being, especially in the current era in which caregivers are assuming increased responsibility for providing patient care.
Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation.Transplantation; 04/01/2007; 83: 7 (858 - 873)
Dew MA, DiMartini AF, De Vito Dabbs A, Myaskovsky L, Steel J, Unruh M,Switzer GE, Zomak R, Kormos RL, Greenhouse JB CHERP Investigator(s):
Larissa Myaskovsky PhD • Galen E Switzer PhD •
Advancing health disparities research within the health care system: a conceptual frameworkAm J Public Health; 12/01/2006; 96: 12 (2113 - 2121)
Kilbourne AM, Switzer G, Hyman K, Crowley-Matoka M, Fine MJ CHERP Investigator(s):
Megan Crowley Matoka PhD • Amy M Kilbourne PhD, MPH • Michael J Fine MD, MSc • Galen E Switzer PhD • Kelly B Burkitt PhD •
Development of a symptom assessment instrument for chronic hemodialysis patients: the Dialysis Symptom Index.J Pain Symptom Manage.; 03/01/2004; 27: 3 (226 - 240)
Weisbord SD, Fried LF, Arnold RM, Rotondi AJ, Fine MJ, Levenson DJ, Switzer GE. CHERP Investigator(s):
Linda F Fried MD, MPH • Michael J Fine MD, MSc • Galen E Switzer PhD • Steven Weisbord MD, MSc •
Associations of race with depression and symptoms in patients on maintenance haemodialysisNephrol Dial Transplant; 01/01/2007; 22: 1 (203 - 208)
Weisbord SD, Fried LF, Unruh ML, Kimmel PL, Switzer GE, Fine MJ, Arnold RM CHERP Investigator(s):
Linda F Fried MD, MPH • Michael J Fine MD, MSc • Galen E Switzer PhD • Steven Weisbord MD, MSc • Summary:
Although studies have shown that African American haemodialysis patients report better overall quality of life than Whites, racial differences in depression and symptom burden remain less well characterized. We surveyed African American and White maintenance haemodialysis patients. Among the 82 Whites and 78 African Americans enrolled, there were no racial differences in the prevalence of depression (27% in African Americans vs 27% in Whites, P = 1.0), BDI Scores (11.2 vs 10.9, P = 0.6) or CDI scores (6.0 vs 6.0, P = 0.9). Symptom burden was substantial in both African Americans and Whites (median number of symptoms 8.5 and 9.0, respectively) with no racial differences in the overall burden or severity of symptoms. However, based on a single item, African Americans were more likely to describe their religious/spiritual beliefs as "very important". Adjustment for demographic and treatment characteristics had no impact on the associations of race with depression or symptoms. Depression and symptoms are highly prevalent in both African American and White haemodialysis patients, without racial differences in these health-related domains.
Donating stimulated peripheral blood stem cells versus bone marrow: do donors experience the procedures differently?Bone Marrow Transplant; 05/01/2001;
Switzer GE;Goycoolea JM;Dew MA;Graeff EC;Hegland J CHERP Investigator(s):
Galen E Switzer PhD • Summary:
In process.
Primary care physicians' atitudes regarding sexually transmitted diseasesSex Transm Dis; 04/01/2002;
Ashton MR;Cook RL;Wisenfeld HC Krohn MA;Zamborsky T;Scholle SH;Switzer GE CHERP Investigator(s):
Galen E Switzer PhD • Summary:
In process.
Non-HLA barriers to unrelated donor stem cell transplantationBone Marrow Transplant; 03/01/2001;
Kollman C;Weis T;Switzer GE;Halet M;Kitajama D;Hegland J;Confer D CHERP Investigator(s):
Galen E Switzer PhD • Summary:
In process.
Patient satisfaction in resident and attending primary care clinicsJGIM; 01/01/2001;
Yancy WS;Macpherson DS;Buranosky RA;Hanusa BH;Arnold RM;Switzer GE;Kapoor WN CHERP Investigator(s):
Galen E Switzer PhD • David S Macpherson MD, MPH • Summary:
In process.
Social stigma and negative consequences: factors that influence college students' decisions to seek testing for sexually transmitted diseasesAm J Coll Health; 12/31/1999;
Barth KR;Cook RL;Downs JS;Switzer GE;Fischoff B CHERP Investigator(s):
Galen E Switzer PhD • Summary:
In process.
What factors influence physicians' decisions to switch from intravenous to oral antibiotics for community-acquired pneumoniaJ Gen Intern Med; 09/01/2001;
Halm EA;Switzer GE;Mittman BS;Walsh MB;Chang CH;Fine MJ CHERP Investigator(s):
Michael J Fine MD, MSc • Galen E Switzer PhD • Mary B Walsh RN • Summary:
In process.
|
